Powering The Future Of Genetic Medicines
4D Molecular Therapeutics (4DMT) is a clinical-stage biopharma company inventing genetic medicines using its Therapeutic Vector Evolution platform to create customized AAV vectors for targeted gene delivery. The company focuses on retina and pulmonology indications, including wet AMD, DME, and cystic fibrosis. Founded in 2013, 4DMT is headquartered in Emeryville, California.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2020
Jun 2020
Sep 2018
Aug 2015
Create a free account to see which investors have funded this company.
Create Free Account
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Outpatient mental health provider offering in-person and virtual therapy, psychiatry, and psychol...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Leading provider of diversified home and community-based health and pharmacy services to medicall...
Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...
